MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RVVTF
  4. News
RVVTF
Quote
Short
News
Articles
Message Board

Revive Therapeutics Ltd (OTCMKTS : RVVTF ) News

Revive Therapeutics Ltd (OTCMKTS: RVVTF) News Releases

RVVTF News Releases
RVVTF : OTC
ACCESS Newswire
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
RVVTF : OTC
SeekingAlpha
Revive Therapeutics announces extension of proposed private placement
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Announces Extension of Proposed Private Placement
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Announces Proposed Private Placement and Debt Settlement
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
RVVTF : OTC
GlobeNewswire
Revive Therapeutics Advances with Next-Generation Bucillamine Development

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.